Inventor
KARSTEN BECKMANN
Inventor
DE
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides23%
H10NElectric solid-state devices not otherwise provided for14%
G11CStatic stores9%
H01LSemiconductor devices5%
H10BElectronic memory devices5%
PatentTitleYear
12,565,533Agonistic CD40 antibodies202612,538,717Resistive random access memory device202611,932,693Monoclonal antibodies directed against programmed death-1 protein and their use in medicine202411,737,286Selector devices for a memory cell202311,702,478Agonistic CD40 antibodies202311,639,392Anti-IL-1R3 antibodies for use in inflammatory conditions202311,637,242Methods for resistive RAM (ReRAM) performance stabilization via dry etch clean treatment202311,352,432Antibodies specifically binding to human IL-1R72022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to MAB DISCOVERY GMBH (3)· patent assignee history
2022–2026Based in DE· patent location history
2023–2026Patents assigned to UNIV NEW YORK STATE RES FOUND (2)· patent assignee history
2023Patents assigned to SANOFI BIOTECHNOLOGY (1)· patent assignee history
2023–2026Based in US· patent location history
2024Patents assigned to BioNTech SE (1)· patent assignee history
2024Patents assigned to GENMAB AS (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MAB DISCOVERY GMBH | 3 | 2022–2026 |
| UNIV NEW YORK STATE RES FOUND | 2 | 2023–2026 |
| BioNTech SE | 1 | 2024 |
| GENMAB AS | 1 | 2024 |
| SANOFI BIOTECHNOLOGY | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 5 | 2022–2026 |
| US | 3 | 2023–2026 |